Category: News

Galilee Energy (ASX: GLL) is about to kick off a six week gas drilling program in the Galilee Basin of western Queensland. This drill campaign adds to the existing gas output of Galilee’s flagship Glenaras project.

Amaero International (ASX: 3DA) is an additive manufacturing company that specialises in 3D printing metal components as well as producing machines and metal powders.

North Stawell Minerals (ASX: NSM) Gold IPO is closing this week. Whilst the deal is over subscribed Reach Markets has a small allocation that we expect to close out very soon. Click here to request a Prospectus and for the opportunity to participate in this IPO. 

In the next episode of our exciting ‘Meet the Funds Manager’ webcast series we will be joined by Ron Shamgar, the Head of Australian Equities at Tamim Asset Management. The Tamin All Cap Fund performed exceptionally strongly through 2019, returning 55.78% (net of fees). And, so far in FY20, is 8.64% (net of fees) up for the year, after a strong July returned 11.34%.

The disruption caused by everyday activities being forced online due to COVID-19 social distancing cannot be underestimated. Entire multi-billion dollar industry verticals such as education, healthcare and security are all scrambling for short-term stop-gaps, many not recognising the permanence of the change brought about by the pandemic, which continues to spread across the world. 

Australian listed biotechnology company Prescient Therapeutics (ASX: PTX) today updated the market on progress on one of its personalised cancer therapy drugs, PTX-100. The results of the Phase 1b study means that PTX-100 can now move to the next level dose with two out of three patients from the first cohort showing stable or improved disease.

When the market collapsed in March, it fell faster than the GFC. Yet it’s since rallied 35% and the V-shaped recovery is moving towards new highs. Meanwhile, there’s a discrepancy between the market’s behaviour and that of the wider economy. This could indicate we’re heading for another collapse.

Australian listed biotechnology company Prescient Therapeutics (ASX: PTX) today updated the market on progress on one of its personalised cancer therapy drugs, PTX-100. The results of the Phase 1b study means that PTX-100 can now move to the next level dose with two out of three patients from the first cohort showing stable or improved disease.

Titomic (AX: TTT) is an additive manufacturing company that showcases Australia’s potential in advanced, green technology. Titomic specialises in 3D printing high-performance metals for the same cost of traditional manufacturing. As well as producing metals, Titomic conducts its own Research & Development.

As gold runs at all time highs and Victoria ushers in a new gold rush, North Stawell Minerals (ASX: NSM) has launched its initial public offering. Talk about perfect timing!The IPO will raise AUD $20 million through 40 million shares at $0.50 a piece.

Optima Nutricosmetics is an Australian nutricosmetics company that offers daily collagen-based supplements that promote skin and gut health.

Every year 45,000 of the most respected professionals in oncology gather at the American Society of Clinical Oncology (ASCO) annual meeting. This year the meeting was abuzz with clinical research news about CAR T-cell therapy, including Johnson and Johnson reporting a 100% recovery rate from its ongoing multiple myeloma (Blood Cancer) trial. The headline grabbing efficacy number is that there are now 25 complete responders in the 29-strong Cartitude-1 dataset. Earlier data cut had reported 22 complete remissions.